Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages

Journal of Investigative Dermatology

Volumn 118, Issue 3, 2002, Pages 505-512

  Olie, Robert A ^a   Hafner, Christoph ^a   Küttel, Renzo ^a   Sigrist, Brigitte ^a   Willers, Jörg ^b   Dummer, Reinhard ^b   Hall, Jonathan ^c   Stahel, Rolf A ^a   Zangemeister Wittke, Uwe ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Antisense; Apoptosis; bcl 2; bcl xL; Melanoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CANCER STAGING; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0036121142     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.01677.x     Document Type: Article

References (36)

1. Bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi
2. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model
3. Swiss guidelines for the treatment and follow-up of cutaneous melanoma
4. Apoptosis in cancer therapy: Crossing the threshold
5. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins
6. Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions
7. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
8. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma
9. Isolation and characterization of an apoptosis-resistant variant of human leukemia HL-60 cells that has switched expression from Bcl-2 to Bcl-xL
10. Inhibition of death receptor signals by cellular FLIP
11. Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
12. Chemosensitisation of malignant melanoma by BCL2 antisense therapy
13. Antisense bcl-2 treatment increases programmed cell death in non-small cell lung cancer cell lines
14. Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-x) on cellular susceptibility to radiation in pancreatic cancer cells
15. Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment
16. Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
17. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
18. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy
19. Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: Progress and therapeutic potential
20. Autoimmunity and the immunotherapy of cancer: Targeting the 'self' to destroy the 'other'
21. Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture
22. Malignant melanoma arising from nevi, p53, p16 and Bcl-2 expression in benign versus malignant components
23. Bcl-2 protein expression in melanocytic neoplasms of the skin
24. Immunohistochemical expression of Bcl-2 in melanomas and intradermal nevi
25. Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines
26. Bcl-xl antisense treatment induces apoptosis in breast carcinoma cells
27. Bcl-2 and Bcl-xL can differentially block chemotherapy-induced cell death
28. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
29. Expression of apoptosis regulators in cutaneous malignant melanoma
30. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells
31. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma
32. The National Cancer Database: Report on melanoma
33. Bcl-2 expression in human melanocytes and melanocytic tumors
34. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM- 1 molecules
35. Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines
36. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells